Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2009 Oct;17(5):438–441. doi: 10.1097/PAI.0b013e3181993d86

Table 3.

Comparison of targeted area and area obtained on TMA, per core

Target diagnosis TMA diagnosis Frequency Percent (%)
Normal TDLUs ducts only 36 3.3
Normal TDLUs normal TDLUs 545 49.8
Normal TDLUs stroma 322 29.4
Normal TDLUs apocrine metaplasia 24 2.2
Normal TDLUs UDH 10 0.9
Normal TDLUs no tissue 158 14.4
Total Normal TDLUs 1095 100.0

UDH ducts only 4 0.9
UDH normal TDLUs 75 16.7
UDH stroma 121 26.9
UDH apocrine metaplasia 26 5.8
UDH UDH 173 38.4
UDH no tissue 51 11.3
Total UDH 450 100.0

ADH ducts only 3 1.8
ADH normal TDLUs 33 20.0
ADH stroma 55 33.3
ADH apocrine metaplasia 3 1.8
ADH ADH 30 18.2
ADH no tissue 41 24.9
Total ADH 165 100.0

ALH ducts only 5 5.6
ALH normal TDLUs 16 17.8
ALH stroma 23 25.6
ALH apocrine metaplasia 2 2.2
ALH ALH 28 31.1
ALH no tissue 16 17.8
Total ALH 90 100.0

Total cores 1,800

TMA=tissue microarray, TDLUs=terminal duct lobular units, UDH=usual ductal hyperplasia, ADH=atypical ductal hyperplasia, ALH=atypical lobular hyperplasia